Overview
Moulid Hidayat practices in Hongo, Japan. Hidayat is rated as an Experienced expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Their top areas of expertise are Cerebral Hypoxia, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Small Cell Lung Cancer (SCLC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaHidayat isExperienced. Learn about Cerebral Hypoxia.
- EGFR Positive Lung CancerHidayat isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung CancerHidayat isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Pulmonary FibrosisHidayat isExperienced. Learn about Pulmonary Fibrosis.
- Small Cell Lung Cancer (SCLC)Hidayat isExperienced. Learn about Small Cell Lung Cancer (SCLC).